Documents

Record revenue growth and market leadership driven by genetics, innovation, and disciplined execution.

Record Q2 revenue and profit growth fueled by strong global sales and product innovation.

All agenda items, including director elections and auditor appointment, were approved without dissent.

Record Q1 revenue, market share gains, and strong cash position set stage for global expansion.

Consumer-driven innovation and global expansion drive growth amid evolving regulatory landscapes.

Record revenue, strong international growth, and major Dutch acquisition set stage for 2026.

Record revenue and margin gains in Q3 2025, with growth set to accelerate in 2026.

Revenue up 21% year-over-year, gross margin at 43%, and strong international growth.

All agenda items, including director elections and auditor appointment, were approved without objection.

International demand and innovation drive growth amid regulatory and tax headwinds.

Q1 2025 saw 28% revenue growth and a return to profitability, fueled by global brand expansion.

Strong Q1 revenue and margin growth, with capacity expansion and share buyback underway.

Strong revenue growth, margin expansion, and market leadership set the stage for 2025.

Q3 2024 revenue jumped 38% to $34.3M, with SpinachⓇ topping Canadian cannabis sales.